Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?

Nguyen, Kimberly H.; Chen, Yutong; Huang, Jing; Allen, Jennifer D.; Beninger, Paul; Corlin, Laura

doi:10.1016/j.ajic.2022.05.024

Cited by 17 publications

(21 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among social and demographic determinants, our findings indicate that booster hesitancy is higher at younger ages [27][28][29] , unlike some previous studies that reported greater booster hesitancy among older persons 30 . Our findings of greater hesitancy among those with lower educational attainment 31 and lower income 17 are consistent with the literature and unchanged from our previous reports 5,6 . Similarly, our booster coverage ranges align with the existing literature-for example, from 7% in China 32 to more than 40% in Jordan 33 , Malaysia 30 and the United States 31 .…”

Section: Discussionsupporting

confidence: 91%

“…Half of respondents (50.3%) were women, and one-fifth of respondents (22.2%) Vaccine hesitancy is a complex phenomenon 15 ; prior studies of influenza vaccine hesitancy have identified more than 70 factors that influence it, many of which are time-specific and context-specific 16 . Not surprisingly, the same factors that influence hesitancy to accept an initial COVID-19 dose also drive booster hesitancy: mistrust of government and health authorities, concerns about vaccine safety and efficacy and, in some countries, age and minority race or ethnicity 5,6,17 . The limited efficacy of current COVID-19 vaccines in preventing infection against new circulating variants could also influence acceptance 18 .…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

Lazarus

Wyka

White

et al. 2023

Nat Med

239

111

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Resultsmentioning

confidence: 99%

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

Lazarus

Wyka

White

et al. 2023

Nat Med

239

111

View full text Add to dashboard Cite

show abstract

“…Qin et al [ 14 ] observed that the VBH was higher among people aged ≥ 50 years (81.7% acceptance) than those aged 21–30 years (94.6% acceptance), which is supported by Nguyen KH et al [ 15 ] and Stephen R et al Accordingly, younger age inversely correlated with VBH. However, Petros Galanis et al [ 16 ] reported that fear of poor vaccination outcomes was negatively correlated with age as supported by Yadete et al [ 17 ], Abouzid et al [ 18 ], Batra et al [ 19 ], Neil G bennett et al [ 20 ], Rzymski et al, Wirawan et al [ 21 ], Elise Paul et al [ 22 ], and Xiaoxiao wang et al [ 23 ].…”

Section: Resultsmentioning

confidence: 86%

A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population

et al. 2023

View full text Add to dashboard Cite

Background: While considerable evidence supports the safety and efficacy of COVID-19 vaccines, a sizable population expresses vaccine hesitancy. As per the World Health Organization, vaccine hesitancy is one of the top 10 hazards to global health. Vaccine hesitancy varies across countries, with India reporting the least vaccine hesitancy. Vaccine hesitancy was higher toward COVID-19 booster doses than previous shots. Therefore, identifying factors determining COVID-19 vaccine booster hesitance (VBH) is the sine qua non of a successful vaccination campaign. Methodology: This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) 2020 standards. A total of 982 articles were pooled from Scopus, PubMed and Embase, while 42 articles that addressed the factors of COVID-19 VBH were finally included for further analysis. Result: We identified factors responsible for VBH and divided them into three major groups: sociodemographic, financial, and psychological. Hence, 17 articles stated age to be a major factor for vaccine hesitancy, with most reports suggesting a negative correlation between age and fear of poor vaccination outcomes. Nine studies found females expressing greater vaccine hesitancy than males. Trust deficit in science (n = 14), concerns about safety and efficacy (n = 12), lower levels of fear regarding infection (n = 11), and worry about side effects (n = 8) were also reasons for vaccine hesitancy. Blacks, Democrats, and pregnant women showed high vaccine hesitancy. Few studies have stated income, obesity, social media, and the population living with vulnerable members as factors influencing vaccine hesitancy. A study in India showed that 44.1% of vaccine hesitancy towards booster doses could be attributed dominantly to low income, rural origin, previously unvaccinated status, or living with vulnerable individuals. However, two other Indian studies reported a lack of availability of vaccination slots, a lack of trust in the government, and concerns regarding safety as factors for vaccine hesitancy toward booster doses. Conclusion: Many studies have confirmed the multifactorial nature of VBH, which necessitates multifaceted, individually tailored interventions that address all potentially modifiable factors. This systematic review chiefly recommends strategizing the campaign for booster doses by identifying and evaluating the reasons for vaccine hesitancy, followed by appropriate communication (at both individual and community levels) about the benefits of booster doses and the risk of losing immunity without them.

show abstract

“…While previous studies examined possible reasons for non-vaccination of COVID-19 primary series, 3 no nationally representative study has examined reasons for non-receipt of booster vaccines among parents of children and adolescents. Since updated bivalent COVID-19 boosters were recommended in September 2022 for children 5 years of age and older, it has become more critical to determine the prevalence of non-receipt and understand the reasons, in order to develop appropriate messaging and strategies to protect the nation against COVID-19 disease and death.…”

Section: Introductionmentioning

confidence: 99%